MEDP - Medpace Holdings, Inc.

419.75
2.460   0.586%

Share volume: 363,540
Last Updated: 05-12-2026
Business Services/Services – Research, Development, Testing Labs: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$417.29
2.46
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
50%
Profitability 64%
Dept financing 13%
Liquidity 9%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.00%
1 Month
-16.26%
3 Months
-1.93%
6 Months
-29.01%
1 Year
35.34%
2 Year
7.83%
Key data
Stock price
$419.75
P/E Ratio 
29.60
DAY RANGE
$413.37 - $420.64
EPS 
$16.22
52 WEEK RANGE
$284.48 - $628.92
52 WEEK CHANGE
$43.88
MARKET CAP 
13.628 B
YIELD 
N/A
SHARES OUTSTANDING 
28.560 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.38
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$366,915
AVERAGE 30 VOLUME 
$492,068
Company detail
CEO: August J. Troendle
Region: US
Website: medpace.com
Employees: 5,200
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company was founded in 1992 and is based in Cincinnati, Ohio.

Recent news